Insurance-based differences in time to diagnostic follow-up after positive screening mammography

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 11, 2016, Pages 1474-1482

  Durham, Danielle D ^a   Robinson, Whitney R ^a,b   Lee, Sheila S ^c   Wheeler, Stephanie B ^a,b   Reeder Hayes, Katherine E ^b,c   Bowling, J Michael ^a   Olshan, Andrew F ^a,b   Henderson, Louise M ^a,b,c  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; DELAYED DIAGNOSIS; FEMALE; FOLLOW UP; HEALTH INSURANCE; HUMAN; MAMMOGRAPHY; MEDICAID; MEDICALLY UNINSURED; MEDICARE; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; RADIODIAGNOSIS; TIME; BREAST TUMOR; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; INSURANCE; MIDDLE AGED; NORTH CAROLINA; UNITED STATES;

AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; MAMMOGRAPHY; MEDICALLY UNINSURED; MEDICARE; MIDDLE AGED; NORTH CAROLINA; TIME; UNITED STATES;

EID: 84994384419     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0148     Document Type: Article

References (62)

1. Nasca PC, Pastides H. Fundamentals of cancer epidemiology. 2nd ed. Sudbury, MA: Jones and Bartlett Publishers; 2008.
2. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:727-37.
3. Breen N, Yabroff KR, Meissner HI. What proportion of breast cancers are detected by mammography in the United States? Cancer Detect Prev 2007;31:220-4.
4. Weaver DL, Rosenberg RD, Barlow WE, Ichikawa L, Carney PA, Kerlikowske K, et al. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer 2006;106:732-42.
5. Sprague BL, Gangnon RE, Hampton JM, Egan KM, Titus LJ, Kerlikowske K, et al. Variation in breast cancer-risk factor associations by method of detection: results from a series of case-control studies. Am J Epidemiol 2015;181:956-69.
6. Chiarelli AM, Halapy E, Nadalin V, Shumak R, O'Malley F, Mai V. Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000. Eur J Cancer Prev 2006;15:34-42.
7. Paquette D. Performance of screening mammography in organized programs in Canada in 1996. The database management subcommittee to the national committee for the canadian breast cancer screening initiative. Can Med Assoc J 2000;163:1133-8.
8. National Breast andCervical Cancer Early Detection Program (NBCCEDP): About The Program 2011 [cited 2016 April 26]. Available from: http://www.cdc.gov/cancer/nbccedp/about.htm.
9. National Breast and Cervical Cancer Early Detection Program (NBCCEDP) Screening Program Data: Interpretation and Use of Data 2011 [cited 2016 April 26]. Available from: http://www.cdc.gov/cancer/nbccedp/data/.
10. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 1999;79:858-64.
11. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 1999;353:1119-26.
12. Ryerson AB, Miller JW, Eheman CR, Leadbetter S, White MC. Recent trends in U.S. mammography use from 2000-2006: A population-based analysis. Prev Med 2008;47:477-82.
13. Kothari A, Fentiman IS. Diagnostic delays in breast cancer and impact on survival. Int J Clin Pract 2003;57:200-3.
14. Sainsbury R, JohnstonC,Haward B. Effect on survival of delays in referral of patients with breast-cancer symptoms: A retrospective analysis. Lancet 1999;353:1132-5.
15. Cancer Facts&Figures2011.Atlanta,GA:AmericanCancer Society;2011[cited 2016 April 26]. Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-029771.pdf.
16. Yabroff KR, Breen N, Vernon SW, Meissner HI, Freedman AN, Ballard-Barbash R. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey. Cancer Epidemiol Biomarkers Prev 2004;13:723-32.
17. Mandelblatt JS, Yabroff KR, Kerner JF. Equitable access to cancer services. Cancer 1999;86:2378-90.
18. Bobo JK, Shapiro JA, Schulman J, Wolters CL. On-schedulemammography rescreening in the national breast and cervical cancer early detection program. Cancer Epidemiol Biomarkers Prev 2004;13:620-30.
19. Roetzheim RG, Pal N, Tennant C, Voti L, Ayanian JZ, Schwabe A, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 1999;91:1409-15.
20. Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: A retrospective analysis. Lancet Oncol 2008;9:222-31.
21. Ward E, Halpern M, Schrag N, Cokkinides V, DeSantis C, Bandi P, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin 2008;58:9-31.
22. Hsia J, Kemper E, Kiefe C, Zapka J, Sofaer S, Pettinger M, et al. The Importance of health insurance as a determinant of cancer screening: evidence from the women's health initiative. Prev Med 2000;31:261-70.
23. RobbinsAS, Lerro CC, Barr RD. Insurance status and distant-stage disease at diagnosis among adolescent and young adult patients with cancer aged 15 to 39 years: national cancer data base, 2004 through 2010. Cancer 2014;120:1212-9.
24. Robert Lukavsky MD, Jack SariegoMD. Insurance status effects on stage of diagnosis and surgical options used in the treatment of breast cancer. South Med J 2015;108:258-61.
25. Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, et al. Breast cancer surveillance consortium: A national mammography screening and outcomes database. Am J Roentgenol 1997;169: 1001-8.
26. Breast Cancer Surveillance Consortium (BCSC). Data Dictionary and Standard definitions. [updated 2009 Sep 16; cited 2016 Apr 26] Available from:http://breastscreening.cancer.gov/data/elements.html#definitions.
27. Eberl MM, Fox CH, Edge SB, Carter CA, Mahoney MC. BI-RADS classification for management of abnormal mammograms. J Am Board Fam Med 2006;19:161-4.
28. Ciatto S, Houssami N, Apruzzese A, Bassetti E, Brancato B, Carozzi F, et al. Categorizing breast mammographic density: intra-and interobserver reproducibility of BI-RADS density categories. Breast 2005;14:269-75.
29. Sickles E, D'Orsi C, Bassett L. ACR BI-RADS Atlas Breast Imaging Reporting and Data System. Reston, VA: American College of Radiology; 2013.
30. Zapka JM, Edwards HM, Chollette V, Taplin SH. Follow-up to abnormal cancer screening tests: considering the multilevel context of care. Cancer Epidemiol Biomarkers Prev 2014;23:1965-73.
31. Taplin SH, Yabroff KR, Zapka J. A multilevel research perspective on cancer care delivery: The example of follow-up to an abnormal mammogram. Cancer Epidemiol Biomarkers Prev 2012;21:1709-15.
32. Chang SW, Kerlikowske K, Napoles-Springer A, Posner SF, Sickles EA, Perez-Stable EJ. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer 1996;78:1395-402.
33. Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB. Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care 2005;43:141-8.
34. Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med 2006;166:2244-52.
35. Caplan LS, Helzlsouer KJ, Shapiro S, Freedman LS, Coates RJ, Edwards BK. System delay in breast cancer in whites and blacks. Am J Epidemiol 1995;142:804-12.
36. Eheman CR, Benard VB, Blackman D, Lawson HW, Anderson C, Helsel W, et al. Breast cancer screeningamong low-incomeoruninsuredwomen: results from the national breast and cervical cancer early detection program, July 1995 toMarch 2002 (United States). CancerCauses Control 2006;17:29-38.
37. Richardson LC, Royalty J, Howe W, Helsel W, Kammerer W, Benard VB. Timeliness of breast cancer diagnosis and initiation of treatment in the national breast and cervical cancer early detection program, 1996-2005. Am J Public Health 2010;100:1769-76.
38. Clark CR, Baril N, Kunicki M, Johnson N, Soukup J, Ferguson K, et al. Addressing social determinants of health to improve access to early breast cancer detection: results of the Boston REACH 2010 breast and cervical cancer coalition women's health demonstration project. J Womens Health 2009;18:677-90.
39. Coburn N, Fulton J, Pearlman DN, Law C, DiPaolo B, Cady B. Treatment variation by insurance status for breast cancer patients. Breast J 2008;14: 128-34.
40. Press R, Carrasquillo O, Sciacca RR, Giardina EG. Racial/ethnic disparities in time to follow-up after an abnormal mammogram. J Womens Health 2008;17:923-30.
41. Ashing-Giwa KT, Gonzalez P, Lim JW, Chung C, Paz B, Somlo G, et al. Diagnostic and therapeutic delays among a multiethnic sample of breast and cervical cancer survivors. Cancer 2010;116:3195-204.
42. Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff JM, Flagg EW, et al. Racial differences in diagnosis, treatment, and clinical delays in a populationbased study of patients with newly diagnosed breast carcinoma. Cancer 2014;100:1595-604.
43. Primeau S, Freund K, Ramachandran A, Bak S, Heeren T, Chen C, et al. Social service barriers delay care among women with abnormal cancer screening. J Gen Intern Med 2004;29:169-75.
44. Kwok J, Langevin SM, Argiris A, Grandis JR, Gooding WE, Taioli E. The impact of health insurance status on the survival of patients with head and neck cancer. Cancer 2010;116:476-85.
45. McWilliams JM, Zaslavsky AM, Meara E, Ayanian JZ. Impact of Medicare coverage on basic clinical services for previously uninsured adults. J Am Med Assoc 2003;290:757-64.
46. Sommers BD, Rosenbaum S. Issues in health reform: how changes in eligibility may move millions back and forth between Medicaid and insurance exchanges. Health Affair 2011;30:228-36.
47. Hoffman HJ, LaVerda NL, Levine PH, Young HA, Alexander LM, Patierno SR, et al. Having health insurance does not eliminate race/ethnicityassociated delays in breast cancer diagnosis in the District of Columbia. Cancer 2011;117:3824-32.
48. Katz ML, Young GS, Reiter PL, Battaglia TA, Wells KJ, Sanders M, et al. Barriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care. Womens Health Issues 2014;24:e155-e62.
49. Adams SA, Smith ER, Hardin J, Prabhu-Das I, Fulton J, Hebert JR. Racial differences in follow-up of abnormal mammography findings among economically disadvantaged women. Cancer 2009;115:5788-97.
50. Henson RM, Wyatt SW, Lee NC. The national breast and cervical cancer early detection program: A comprehensive public health response to two major health issues for women. J Public Health Manag Pract 1996;2:36-47.
51. ChiarelliAM,Mai V, Halapy EE, Shumak RS,O'Malley FP, Klar NS. Effect of screening result on waiting times to assessment and breast cancer diagnosis: results from the Ontario Breast Screening Program. Can J Public Health 2005;96:259-63.
52. Caplan LS, May DS, Richardson LC. Time to diagnosis and treatment of breast cancer: results from the national breast and cervical cancer early detection program, 1991-1995. Am J Public Health 2000;90:130-4.
53. Wernli KJ, Aiello Bowles EJ, Haneuse S, Elmore JG, Buist DSM. Timing of follow-up after abnormal screening and diagnostic mammograms. Am J Manag Care 2011;17:162-7.
54. Karliner LS,Ma L, Hofmann M, Kerlikowske K. Language barriers, location of care, and delays in follow-up of abnormal mammograms. Med Care 2012;50:171-8.
55. Rosenberg RD, Haneuse SJ, Geller BM, Buist DS,Miglioretti DL, Brenner RJ, et al. Timeliness of follow-up after abnormal screening mammogram: variability of facilities. Radiology 2011;261:404-13.
56. Lobb R, Allen JD, Emmons KM, Ayanian JZ. Timely care after an abnormal mammogram among low-income women in a public breast cancer screening program. Arch Intern Med 2010;170:521-8.
57. Jones B, Dailey A, Calvocoressi L, Reams K, Kasl S, Lee C, et al. Inadequate follow-up of abnormal screening mammograms: findings from the race differences in screening mammography process study (United States). Cancer Cause Control 2005;16:809-21.
58. Caplan LS, Helzlsouer KJ, Shapiro S, Wesley MN, Edwards BK. Reasons for delay in breast cancer diagnosis. Prev Med 1996;25:218-24.
59. Zapka JG, Bigelow C, Hurley T, Ford LD, Egelhofer J, Cloud WM, et al. Mammography use among sociodemographically diverse women: The accuracy of self-report. Am J Public Health 1996;86:1016-21.
60. Yu S-T, Chang H-Y, Lin M-C, Lin Y-H. Agreement between self-reported and health insurance claims on utilization of health care: A population study. J Clinical Epidemiol 2009;62:1316-22.
61. Neuman MI, Radeos MS, Yang A, Gordon JA, Camargo CAJr. Does parental report of insurance status agree with hospital administrative data for children presenting to the ED? Am J Emer Med 2006;24:890-2.
62. Fair AM, Wujcik D, Lin JMS, Grau A, Wilson V, Champion V, et al. Obesity, gynecological factors, and abnormal mammography follow-up in minority and medically underserved women. J Womens Health 2009;18:1033-9.